Cheryn W. Song
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 115 publications
Linker-dependent variations in the tumoricidal activity of DZ-1-dihydroartemisinin conjugate formats.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 20, 2026
Oncologic outcomes and renal function preservation after stereotactic ablative body radiotherapy versus radiofrequency ablation in stage I renal cell carcinoma.
Journal: Clinical and translational radiation oncology
Published: March 22, 2026
Tumoricidal efficacy of DZ-1 dye conjugated to dihydroartemisinin in patient-derived colorectal liver metastasis tumoroids.
Journal: Molecular therapy. Oncology
Published: January 10, 2026
DZ-1-Artesunate Induces Apoptosis Via a Bid-, Bax-, and Bak-Independent Caspase-3 Activation Pathway.
Journal: Journal of oncology research and therapy
Published: December 01, 2025
DZ-1-artesunate conjugate induces mitochondria-mediated, reactive oxygen species-dependent apoptosis in colorectal cancer tumoroids.
Journal: Frontiers in pharmacology
Published: November 10, 2025
Artificial intelligence-based personalized oncological outcome prediction model for upper urinary tract urothelial carcinoma after radical nephroureterectomy: A development and multicenter validation.
Journal: Investigative and clinical urology
Published: August 10, 2025
Papillary renal neoplasm with reverse polarity shows benign behavior: Results from a 77-case clinicopathological and molecular study.
Journal: Annals of diagnostic pathology
Published: February 23, 2025
Comparative analysis of oncologic outcomes in surgically treated patients with renal cell carcinoma and renal vein thrombosis by pathologic subtypes.
Journal: Scientific reports
Published: January 10, 2025
Last Updated: 09/26/2026